Rob de Ree Chief Executive Officer Prior to joining NorthSea Therapeutics B.V., Rob de Ree served as the CEO of the start-up companies Dezima Pharma, which was acquired by Amgen in 2015 and as the CEO of BMEYE which was acquired by Edwards lifesciences in 2012. Before...
Hilde H. Steineger Chief Operating Officer (COO), Co-founder Hilde H. Steineger, a co-founder of NorthSea Therapeutics B.V., formerly served as Head of Strategic Innovation Management in Nutrition and Health Division (EN), BASF and Head of Global Omega-3 innovation...
David A. Fraser Chief Scientific Officer (CSO), Co-founder Dr. David A. Fraser, a co-founder of NorthSea Therapeutics B.V., formerly worked as Group Lead Discovery R&D at Pronova Biopharma AS, part of BASF. Prior to joining Pronova in 2008, he worked as a...
Tore Skjæret VP Chemistry, Co-founder Tore Skjæret, a co-founder of NorthSea Therapeutics B.V., formerly worked as Group Lead, Medicinal Chemistry and production readiness at the Discovery R&D department at Pronova Biopharma AS, part of BASF, where he was...
Mats Blom Chief Financial Officer (CFO) Mats Blom has extensive managerial experience and has held CFO positions in several public and non-public companies. He has served as CFO of Zealand Pharma A/B, a biotechnology company dual listed at Nasdaq in New York and...
